In Vivo CAR T: A New Route to Treating Autoimmune Disease
How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments
False
Advertisement
Related Content
Drug Discovery
Development & Clinical
Future of Pharma
Can Better Biomarkers Reduce Drug Failure?
November 12, 2026
5 min read
How next-generation biomarker strategies could improve patient stratification, strengthen clinical trials, and reduce the cost of drug development
Development & Clinical
Formulation
Biopharma
Analytical Champions: Sarah O’Keeffe
November 10, 2026
14 min read
Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
Cell & Gene
Development & Clinical
Technology & Manufacturing
Preparing Community Hospitals for CAR T’s Expansion
November 5, 2026
6 min read
By choosing where to participate and working with specialist partners, community hospitals can bring more of the CAR T patient journey closer to home
Drug Delivery
Interviews
Putting Patients in Control of Self-Injection
November 4, 2026
5 min read
West Pharmaceutical Services’ Whitney Winters discusses how injection device design can support patient comfort, confidence, and independence